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Abstract There has been increasing interest lately in
understanding how natural dietary antioxidants affect che-
moprevention, and recently, there has been a merging of
information about antioxidants, endogenous and exoge-
nous reactive oxygen and nitrogen species (RONS), and
inflammation. RONS normally serve the cells as second
messengers to regulate many of the intracellular signaling
cascades that govern multiple cellular activities. However,
when the amount of RONS exceeds the cell’s ability to
metabolize/eliminate them, the cell becomes stressed and
acquires genetic and epigenetic aberrations and dysregu-
lated intracellular signaling cascades. In addition, there
has been a better understanding of the role of tissue
inflammation in the carcinogenesis process. Herein we
integrate these fields to explain where RONS arise
and how natural dietary antioxidants are principally
working through refurbishing pathways that use RONS
as second messengers.
Keywords Gene-diet interaction . Colon cancer . Colorectal
cancer . NADPH oxidases . H2O2 . NOS2 . Inflammation .
Free radicals . RONS . Epigenome . miRNA . NF-κB .
COX-2 . Nrf2 . WNT . Chemoprevention . Fusobacterium
nucleatum bacteria . PTEN . AKT .Macrophages .
Neutrophils . K-ras
Introduction
Reactive oxygen (ROS) and nitrogen (NOS) species
(RONS) normally regulate many of the intracellular
signaling cascades that govern multiple cellular activities.
However, when the amount of RONS exceeds the cell’s
ability to metabolize/eliminate them, the cell becomes
stressed and acquires genetic and epigenetic aberrations.
Excess RONS also dysregulated intracellular signaling cas-
cades. Thus, antioxidation of excess levels of RONS is
crucial for reducing the risk of developing cancer. The
primary rationale for this conclusion is the marked increased
risk of developing cancer in patients with ulcerative colitis
and Crohn’s disease [1, 2••]. A strong case has also been
made for a major role of inflammation and RONS in the
carcinogenesis of the more prevalent sporadic form of colon
cancer [3]. Specifically, McLean and associates [4•] recently
reported an extensive immunohistochemical study that
clearly showed significant infiltration of proinflammatory
cells, including macrophages expressing inducible nitric
oxide synthase (NOS2; also known as iNOS) in adenoma-
tous lesions. NOS2 is an enzyme that converts arginine to
citrulline plus the radical nitric oxide (NO●−). The radical
itself is oxidative, and also because it generates the radical
peroxynitrite (OONO−) when it combines with O2●−.
Other support for a role of inflammation and RONS in
colon carcinogenesis is that NSAIDs reduce the risk of
developing this disease [5], and the frequently noted over-
expression of NADPH oxidase enzymes (NOX) that pro-
duce superoxide (O2 ) and H2O2, which dissociates to the
HO− radical [6]. Thus, inflammatory-associated RONS are a
key player in the genesis of this disease. Chemopreventative
foods and their active constituents have been shown to
decrease the number and size of colon cancer in animal
models and recently in humans as well. The paramount
feature of the vast majority of these chemopreventive sub-
stances is their ability to antagonize proinflammatory cyto-
kines and chemokines and reduce the level of RONS.
Therefore, it is expected that molecular pathways most
commonly affected by chemopreventive agents would be
those that are dysregulated by proinflammatory factors and
free radicals.
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The Inflammatory Microenvironment
The primary condition that initiates stress to epithelial cells is
an inflammatory microenvironment [1, 2••, 3, 4•, 7–14],
wherein infiltrating lymphocytes and macrophages raise the
level of RONS to amounts that exceed the ability of the cell to
eliminate them by its antioxidant phase II enzymes (eg, super-
oxide dismutase, catalase, glutathione peroxidase, and perox-
iredoxins, glutathione-S-transferase, quinone oxidoreductase,
epoxide hydrolase, and others). The inflammatory microenvi-
ronment of colon lesions contains many RONS-producing cell
types, including neutrophils, monocytes, Tand B lymphocytes,
macrophages, and natural killer cells. Some of these cells
release a number of growth factors and cytokines (eg, trans-
forming growth factor-β [TGF-β]), and chemokines (eg,
CCL2, CCL7, CCL3, CCL4, CXCL12, and interleukin [IL]-
8), along with tumor necrosis factor (TNF)-α. These factors
chemoattract monocytes and macrophages. When chronically
activated, this inflammatory/oxidative environment becomes a
relentless cycle that results in genetic and pathological damage
to the apposition epithelium [14].
Some of the procarcinogenic activity of the infiltrating
lymphocytes is caused by their release of ROS as they
phagocytize Fusobacterium nucleatum bacteria. Previously
known as a periodontal pathogen, this microbe is a rare
member of the fecal microbiota of noncancerous patients.
However, it is prevalent in polyps and is a major resident in
tumor tissue. When tested with peripheral blood lympho-
cytes, the oxidative burst produced by phagocytizing F.
nucleatum was significantly greater than those from other
species of bacteria. At the same time, this microbe indirectly
caused differential expression of 208 genes in the lympho-
cyte. Seven percent of these genes were transcription regu-
lators, 13 % were involved in signal transduction, and 14 %
were ROS-response genes. The primary enzyme that produ-
ces these radicals is the NOX family gene NADPH oxidase
2 (NOX2), which produces O2 [15, 16].
One natural dietary constituent (NDC) that may affect the
O2 produced by NOX2 infiltrating proinflammatory cells is
dark cocoa, which antagonizes NOX2 activation. [17] Co-
coa contains relatively high amounts of the flavonoid epi-
catechin and has been found to have nearly twice the
antioxidant content of red wine and up to three times that
of green tea when assessed in vitro. One mechanism is that
flavonoids can bind directly to some protein kinases and
thereby antagonize the consequences of ROS-inactivated
phosphatases (see below). Fish oil diet has also been shown
to reduce inflammation in a rat colon carcinogenesis model.
The suspected target is NOX2, but the mechanism has not
been elucidated [18].
Regarding inflammatory cytokines, the NDC astaxanthin
suppresses colon carcinogenesis in mice, partly through
inhibition of the expression of inflammatory cytokines
[19]. The combination of β-cryptoxanthin, a carotenoid,
and hesperidin, a flavonoid extracted from the Mandarin
orange, also suppresses the expression of proinflammatory
cytokines [20], but the mechanism has not been described.
Other NDCs, such as the antioxidant curcumin, a polyphe-
nol extracted from turmeric, act through the inhibition of
phosphorylation of the inhibitor of κB (IκB), which in turn
reduces the nuclear translocation of nuclear factor-κB (NF-
κB) and thereby silences expression of proinflammatory
cytokines CXCL1 and CXCL2 [21, 22].
Other sources of RONS are the inflammatory cells them-
selves [4•, 14]. One is the recently discovered resident
neutrophil. These unique cells are localized to the crypts
and express the NOX family member NOX1 [23]. Presum-
ably, these normal cells use this enzyme for defense against
the fecal microbiota. On the negative side, when activated,
these adherent lymphocytes are postulated to be involved in
the pathogenesis of inflammatory bowel disease, and they
may also be involved in initiating and maintaining the
micro-inflammatory environment associated with sporadic
colon cancer. Another are the infiltrating activated macro-
phages and monocytes that upregulate NOS2 activity in
response to cytokines [13, 14].
Upregulated NOS2 underpins chronic inflammation in
general and colon carcinogenesis in particular [24]. The
STAT1 signaling cascade is one of the major pathways that
upregulates NOS2 [25]. One antioxidant NDC that antago-
nizes NOS2 in colon inflammatory lesions and cells is the
green tea constituent epigallocatechin gallate (EGCG). This
compound inhibits activation of STAT1 by suppressing
NOX-produced phosphorylation of the pro-STAT1 protein
[26]. Another NDC is cyanidin and its metabolites. These
antioxidant anthocyanidins are found in grape, blackberry,
blueberry, cherry, cranberry, elderberry, and raspberry as
well as apple, plum, red cabbage, and red onion. They work
by attenuating NF-κB activity, which regulates NOX2 tran-
scription through its binding site in the promoter of NOS2
[27]. Another antioxidant is the anthocyanidin resveratrol,
which is obtained from grapes and wine. It inhibits NOS2
induction via inhibiting ROS activation of the p38 and ERK
pathways. It also depresses ROS activation of NF-κB [28].
Another antioxidant is pterostilbene, which is found in
grapes and blueberries. Its mechanism is as that for
resveratrol [29, 30]. Eight other STAT-inhibiting NDCs,
including capsaicin and curcumin, are discussed by
Trecul and coauthors [31].
ROS and NOS Production by Colon Cancer Cells
One way colon cells produce ROS is via xanthine oxidase
(XO), which converts hypoxanthine to xanthine and then
uric acid in the presence of molecular oxygen to yield O2
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and H2O2. There is some evidence that the XO-derived ROS
normally play a role in antimicrobial defense. 1′-acetoxy-
chavicol acetate (ACA), an NDC present in members of the
ginger plant family, is an inhibitor of XO enzymatic activity.
It also upregulates Nrf2, which causes activation of phase II
enzymes [32]. Another source of ROS is the mitochondria,
wherein 1 % to 2 % of the O2 electrons used for producing
adenosine triphosphate (ATP) leak from the electron trans-
port chain as O2 and H2O2 [33].
Very important sources of ROS in the colon are the NOX
enzyme complexes. Family members NOX1 and NOX4
produce abundant amounts of O2 and H2O2 in colon cells
[6, 34]. They are expressed in the crypts and probably play a
role in the innate response by the normal colon to fecal
microbiota [35, 36]. They are unregulated threefold in pre-
cancerous lesions and in tumors. NOX-1 is activated in
colon cells by the proinflammatory factor tumor necrosis
factor (TNF)-α [37]. It is also upregulated by oncogenic ras
[38, 39]. One of the earlier reports showing an important
relationship between NOX1 and colon cancer cells was by
Szanto et al. [40]. These authors showed that antisense
oligonucleotides of NOX1 not only lowered ROS produc-
tion but at the same time reduced the proliferation rate of the
cells. Unfortunately, the literature is lacking information on
any NDCs that can directly diminish the activity of NOX1
or NOX4. On the other hand, potentially all the antioxidant
NDCs may be able to scavenge the ROS produced by these
enzymes before they can produce damage to the cell.
NOX enzymes are protein complexes [41]. Activation of
the oxidase activity is dependent on Rac1, a small G protein.
The binding of growth factors (ie, TGF-α) to their receptors
initiates signal transduction, which activates Ras. Ras trans-
fers the signal to phosphatidylinositde-3 kinase (PI3K). Rac1
is a key downstream target of PI3K, and one of a number of
the protein targets of PI3K kinase activity is a member of the
NOX complex, NOXA1. Thus, Rac1 and NOXA1 facilitates
NOX1 enzyme activity. This growth factor-ras-rac1-NOXA1
signaling pathway partially explains why colon tumor cells
that harbor a mutant K-ras gene, or exhibit overexpression of
growth factors and/or their receptors have constitutively
activated NOX1 activity [38, 42–44].
The downstream targets of the PI3K–Akt pathway are
often abnormally activated in colon because of gain-of-
function mutations that lead to oncogenicity [45]. As a
result, BCL2-antagonist of cell death (BAD) is inhibited
and there is increased cell survival. Recent studies [46]
show that flavonoids such as quercetin and epicatechin can
bind directly to some protein kinases [47], including Akt/
protein kinase, Janus kinase 1 (JAK1), mitogen-activated
protein kinase kinase 1 (MEK1), PI3K, mitogen-activated
protein (MAP) kinase kinase 4 (MKK4), and Raf1, and alter
their phosphorylation state and their ability to regulate mul-
tiple cell-signaling pathways. The polyphenol antioxidant
NDC ellagic acid (obtained from blackberries, cranberries,
pecans, pomegranates, raspberries, strawberries, walnuts,
wolfberry, grapes, and peaches) also prevents PI3K/Akt
activation [48, 49].
The proinflammatory NF-κB, which is a commonly over-
active gene in colon cancer, participates in the control of
transcription of more than 3,000 target genes, including
NOS2, cyclooxygenase 2 (COX-2, also called PTGS2),
NOX1, NOX4, NOX2, interleukins, AKT1, TNF, EGFR,
GADD45B, MAP2K6 (MEK6), NQO1, STAT3, TP53,
BCL2A1, BCL-X, p21CIP1/WAF1, BIRC2, GADD45B,
NQO1, PDGFB, PLAU, SOD2, REL, and MYC. Thus,
NF-κB is involved in the inflammation, formation of DNA
adducts, cell cycle regulation, apoptosis, angiogenesis, and
invasion/migration/metastasis aspects of carcinogenesis
[2••, 8, 33, 50, 51••]. Briefly, in the canonical pathway of
activation, NF-κB is bound to IκBα. The IkappaB kinase
(IKK) complex phosphorylates IκBα, thereby releasing it
from NF-κB. NF-κB then translocates to the nucleus, and
gene transcription ensues [51••]. There is also a second
pathway for activating NF-κB that involves RONS. It has
been shown that TNF-α and IL-1β activate NOX4 (which
does not have NOXA1 or Rac1 within the complex) with a
concomitant rise in ROS. The radicals then activate NF-κB
activity [50]. The central player for this pathway is the redox
switch protein LC8 [52]. LC8 interacts with IκBα in a
redox-dependent manner. In cells exposed to TNF-α or
H2O2, LC8 dissociates from IκBα. The released IκBα is
then phosphorylated by the IKK complex. Thus, ROS can
be responsible for activation of NF-κB. Interestingly, NF-
κB and the other NADPH oxidase in colon cells (NOX1)
regulate each other. This is brought about because the pro-
moter of the NOX1 gene has a consequence sequence for
NF-κB binding [41, 53]. Thus, there is a positive feedback
loop in which NF-κB activation by NOX1-derived O2●−
and H2O2 leads to further induction of NOX1, with ever
greater production of O2●− and H2O2 and ever-increasing
levels of damage to the cells. One of the means of cross-talk
between infiltrating cells and epithelial cells is the STAT3-
NF-κB axis of transcription [54•]. These genes are consti-
tutively activated in colon cancer tumors. STAT3 regulates
numerous genes and NF-κB targets more than 3,000. Acti-
vated infiltrating cells release proinflammatory cytokines
that activate production of STAT3 and NF-κB in the
epithelial cells. In turn, the epithelial cells exhibit in-
creased proliferation, survival, and angiogenesis.
There are numerous antioxidant NDCs that affect NF-κB.
Included within this group is lycopene (from tomatoes,
carrots, red bell peppers, watermelons, and papayas) [55•].
It affects NF-κB through MAPK/ERK and PI3K/Akt sig-
naling pathways that are plausibly dysregulated by RONS.
Thus, lycopene inhibited cell proliferation of human colon
cancer cells via suppression of the Akt signaling pathway
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and downstream targeted molecules. Other antioxidant NDC
affecters of NF-κB are curcumin, the carotenoid astaxan-
thin, and sulforaphane [56]. Sulforaphane is obtained from
cruciferous vegetables such as broccoli, brussel sprouts,
cabbages, garlic, and onions. The anthocyanidin family,
represented by delphinidin (from cranberries, Concord
grapes, and pomegranates), also works by inhibiting NF-
κB activation [57]. Pterostilbene, which is chemically relat-
ed to resveratrol and is found in blueberries and grapes,
reduced NF-κB activation by inhibiting the phosphorylation
of PKC, and decreased downstream target gene expression,
including NOS2, COX-2, and nuclear factor (erythroid-de-
rived 2)-like 2 (Nrf2) signaling [30].
Proinflammatory cytokines upregulate NOS2 in colon
epithelial cells [4•]. NOS2 has a major role in the activation
of COX-2, which is an immediate—early response proin-
flammatory gene that is upregulated in nearly all colon
cancers [58]. COX-2 indirectly regulates gene expression
through metabolizing arachidonic acid (AA) to prostaglan-
din E2 (PGE2). This eicosanoid binds and activates EP
receptors. The receptors regulate several signal transduction
pathways (eg, PKC to ERK, and epidermal growth factor
receptor [EGFR] to AKT). These pathways affect cell pro-
liferation, invasion, survival, and angiogenesis [2••, 59].
Interestingly, in liver cells, NOX1 activation has been
shown to upregulate COX-2 expression and activity, which
in turn induced NOX4 expression and ROS production.
Taken together, these results indicate that the NOX proteins
in colon and COX-2 are reciprocally regulated [60, 61].
Liberation of arachidonic acid by cytosolic phospholi-
pase A(2) (cPLA[2]) is often the initial and rate-limiting
step in leukotriene (LT) and PG biosynthesis. Because
COX-2 enhances the formation of a cPLA(2)alpha-iNOS
binding complex, it appears that COX-2—induced augmen-
tation of cPLA(2)alpha S-nitrosylation is mediated at least
in part through increased association between NOS2 and
cPLA(2)alpha [62]. Therefore, therapy aimed at disrupt-
ing this interplay may represent a promising strategy to
effectively inhibit PGE2 production and thereby prevent
inflammation and carcinogenesis.
Numerous antioxidant NDCs have been identified
that inhibit COX-2. Some of these work indirectly
through inhibiting NF-κB. Included in this list are cur-
cumin, olive oil, resveratrol, EGCG, the flavone apige-
nin (from leafy vegetables [eg, parsley, artichoke, basil,
celery]), the isoflavone genistein (from fava beans and
soy beans), the flavonoid kaempferol (from tea, brocco-
li, grapefruit, and apple), the flavonoid chrysin (from
honey), and sulforaphane [9, 63]. Some of these may
actually be affecting NF-κB expression in the activated
macrophages of the inflammatory lesion.
Arachidonic acid is also metabolized by 5-lipoyxgenase
(5-LOX) to LTs. The enzyme and its metabolites are
elevated in adenomas and are even higher in cancer tumors.
LTs are potent inflammatory mediators that act by stimulat-
ing the G protein—coupled receptors BLT1 and BLT2 that
in turn induce NF-κB, TNF-α, and ILs in the activated
macrophages and leukocytes within the inflammatory le-
sion. Some LOX products are procarcinogenic, while others
are anticarcinogenic. The procarcinogenic enzyme 5-LOX
leads to the production of LTs. 15-LOX-1 has anticarcino-
genic effects. In human colon epithelium, 15-LOX-1 expres-
sion levels are low and NSAIDs induce its expression. Red
ginger has the potential to decrease eicosanoid levels, per-
haps by inhibiting their synthesis from arachidonic acid.
Alternatively, this antioxidant may work indirectly through
scavenging of NO●− [64].
RONS and Mutagenesis
The sequence of some of the genetic changes that correlate
with the observed pathological transformations that occur
during the initiation and promotion/progression stages of co-
lon carcinogenesis was identified more than 25 years ago [1,
2••, 65]. It begins with loss of APC function, as the tissue
changes from normal appearing into an early adenomatous
lesion. Aneuploidy and methylation events arise in the early
adenomatous lesion, andmicrosatellite instability, K-ras muta-
tions, and upregulation of COX-2 develop as the early adeno-
ma evolves into an intermediate adenoma. As this lesion
progresses to the late adenoma stage, there is loss of hetero-
zygosity of the genes deleted in colorectal carcinoma (DCC)
and SMAD family member 4 (SMAD4). Lastly, just before
the onset of clinical cancer, the p53 gene is mutated. These
genetic aberrations are associated with the formation of ROS-
and NOS-caused 8-hydroxy-deoxyguanosine (8-OH-dG)
adducts in the DNA [67]. The result is a GC➔TA base pair
transversion and/or an apurinic/apyrimidinic site if not
repaired before DNA replication occurs. Thus, 8-OH deoxy-
guanosine bases frequently result in mutations in genes (eg,
K-ras and p53). In addition, RONS cause single- and double-
strand breaks, with the result of loss and gain of genetic
information. Radicals also cause DNA-protein cross-links
and pyrimidine and purine lesions. These adversely affect
the integrity of the genome, with genomic instability as one
consequence. Another effect of RONS is reduction of 5-
methyl-deoxycytosine content in DNA [66, 67]. The presence
of oxidized deoxyguanosine reduces ability of the DNA to
serve as a substrate for DNA methyltransferase (DNMT).
Hence, the enzyme does not transfer the methyl group from
methionine to deoxycytosines during DNA replication, and the
level of 5-methyl-cytosines becomes progressively reduced
[67]. This hypomethylation of the cell’s genome correlates
with the onset of genomic instability, microsatellite instability,
and increased mutation rate. DNA hypomethylation also
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causes activation of genes normally transcriptionally down-
regulated by hypermethylation [68] of their promoter region
(ie, the oncogenes H-ras and c-MYC, which are frequently
overexpressed by colon cancer cells). Excess RONS also leads
to shutting off tumor suppressor genes by hypermethylation
of their promoter. However, the mechanism producing this
phenomenon remains obscure.
Antioxidant NDCs scavenge hydroxyl radicals and other
ROS. Apple polyphenols have been shown to elevate ex-
pression of the phase II genes [69]. Tea polyphenols also
induce phase II enzyme activity. Another constituent is the
antioxidant dithiolethione from cruciferous vegetables. It
activates Nrf2 (see below) signaling, which in turn induces
phase II enzymes. Others are sulforaphane, indole-3-
carbinol, and phenethyl isothiocyanate (PEITC) (from
cruciferous vegetables) [70]. The coffee constituents 5-
O-caffeoylquinic acid and N-methylpyridinium have al-
so been identified as inducers of the Nrf2-regulated
detoxifying pathways [71].
Antioxidant NDCs also target the epigenome. Among
these are the polyphenols from green tea, apples and coffee,
genistein, soy isoflavones, curcumin, ellagitannin, indole-3-
carbinol, lycopene, sulforaphane, PEITC, and phenylhexyl
isothiocyanate (PHITC) [72]. Also effective is resveratrol,
which affects the activity of histone deacetylase SIRT1,
which regulates the activity of DNMT1 [73]. Others are
inhibitors of histone acetyl transferases (anacardic acid from
cashew nut), garcinol (from mangosteen), and ursodeoxy-
cholic acid (a metabolic byproduct of intestinal bacteria).
Finally, the relatively unexplored modulators of histone
lysine methylation (chaetocin, a fungal metabolite, and n-3
polyunsaturated fatty acids) may be effective in inhibiting
changes in the epigenome [74]. Also effective in targeting
the epigenome are black raspberries (BRBs). We recently
demonstrated that daily oral administration of BRBs for
4 weeks resulted in protective modulation of multiple epi-
genetic biomarkers (SFRP2, SFRP5, PAX6a, and WIF1) of
the WNT pathway that was modulated in a protective direc-
tion by BRBs in healthy tissues and in colorectal tumors in
cancer patients. This observation was associated with
decreased expression of DNMT1 [75].
RONS-Regulated Signaling Pathways
Low levels of RONS serve as second messengers to
regulate multiple signaling pathways as a way to maintain
cellular homeostasis [76]. RONS accomplish this by using
switching proteins that are reversibly oxidized by H2O2
and returned to their normal state by reducing enzymes.
One switch position is brought about through cysteines
(Cys) on the surface of these proteins. The thiol moiety (-SH)
of these Cys is highly, and in some proteins specifically,
sensitive to oxidation, with the results of the formation of a
sulfenyl moiety that can form a disulfide bond with another
oxidized surface Cys. Consequently, the protein acquires a
structural change and is either inactivated or indirectly acti-
vated (see ASK1 below). The switch is flipped back by
reduction of the Cys by thioredoxin (Trx), thereby establish-
ing “on” and “off” states of molecular pathways regulated by
RONS [76–79].
With respect to carcinogenesis, foremost among the ROS
inactivation switch proteins are members of the large family
of PTPs [76–79]. For example, PTPs have an essential role
in downregulating receptor tyrosine kinase (RTK)-mediated
signaling by dephosphorylating RTKs. On the other hand,
PTP inactivation by NOX-derived ROS enhances RTK ty-
rosine phosphorylation which leads to amplified activity of
the ERK pathway, suggesting that modulation of RTK sig-
naling via PTP inactivation by NOX-derived ROS may have
a significant contribution in mediating the activation of
ERK/MAPK pathway. Another example is the PTEN. Nor-
mally, PTEN dephosphorylates phosphoinositide substrates,
thereby negatively regulating the intracellular levels of
phosphatidylinositol-3,4,5-trisphosphate. The consequence
is negative regulation of the Akt signaling pathway [80].
Alternatively, inactivation of PTEN constitutively acti-
vates the AKT pathway, a major player in colon cancer
carcinogenesis. Most loss of PTEN is attributed to dele-
tions and hypermethylation [65]. However, ROS may
also be a player, as when Cys on PTEN are oxidized,
the enzyme is inactive, and the Akt pathway is upregulated
and cell survival is augmented.
Another ROS-targeted phosphatase activity is the gene
dual specificity protein phosphatase (DUSP) [76–79]. DUSP
negatively regulates the activity of c-Jun N-terminal kinase
(JNK) and p38 mitogen-activated protein kinase (p38) stress
signaling pathways in a way analogous to PTEN. When
DUSP protein is oxidized, its phosphatase activity is inacti-
vated and stress signaling pathways are upregulated. Thus, by
oxidizing DUSP and activating JNK and P38, several impor-
tant cellular functions, including cell growth, differentiation,
survival, and apoptosis, are dysregulated. The Cdc25 phos-
phatases (A, B, and C) that participate in cell cycling are also
oxidized and inactivated by ROS. Central to the cell-cycling
process are the CDKs and their catalytic partners, the cyclins.
The CDKs are negatively regulated by CDK inhibitors (eg,
p16, p21, and p27) and positively activated by CDK-
activating kinases. CDC25 regulates the extent of phosphory-
lation of CDKs at differing times of the cell cycle. Accord-
ingly, when CDC25 is oxidized and inactive, the CDKs are
fully activated throughout the cycle and the cells proliferate
faster. Meeran and Katiyar [81] have discussed the NDCs that
affect the cell-cycling pathway.
The apoptosis signal-regulating kinase 1 (ASK1), which
is a member of the MAPK family, is indirectly activated by
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RONS [76–79]. ASK1 elicits numerous cellular responses
to stress through its activation of the JNK and p38 path-
ways. As noted above, Trx is an antioxidant enzyme. Under
normal conditions, it binds to ASK1 and inhibits its kinase
activity. Under oxidative stress conditions, the two cysteine
residues in the active site of Trx undergo reversible oxida-
tion to form a disulfide bond with each other. Thus, the
conformation of Trx protein is changed, ASK1 dissociates
from Trx, and its kinase activity is turned on.
Another transcription factor activated by RONS is Nrf2
[76–79]. Nrf2 is retained in the cytoplasm and destroyed in the
proteasome when bound to Keap1. Reactive species oxidize
Keap1, thereby permitting Nrf2 to translocate into the nucleus
and activate a myriad of oxidative response genes, whose
resultant enzymes extinguish the negative effects of the ele-
vated levels of RONS. Many antioxidant NDCs increase Nrf2
activity. Interestingly, sulforaphane amplifies Nrf2 activity by
chemically modifying cysteine thiols of Keap1 [82].
Cinnamon is also an activator of Nrf2 [83].
The WNT canonical pathway is commonly activated in
colon cancer [65]. NOX1 and NOX4 have been implicated in
this inappropriate upregulation [6]. In this pathway, the WNT
factor causes the translation of the transcription factor β-
catenin (β-Ctn) into the nucleus. The primary means of acti-
vation of the WNT pathway in colon cancer is through dele-
tions in the adenomatous polyposis coli (APC) gene.
Mutations of APC are considered to be early events in colon
carcinogenesis, thereby explaining why inappropriate expres-
sion of the WNT pathway is one of the earliest events leading
to colon cancer [65]. In normal cells, APC forms a complex
consisting of β-Ctn, casein kinase-1-α, glycogen synthase
kinase-3 (GSK3), and axis inhibitor. GSK3 phosphorylates
β-Ctn, thereby priming it for degradation by the proteasomes.
When the WNT factor binds and activates its receptor frizzled,
the signal is passed to disheveled (Dvl). Dvl binds with the β-
Ctn-APC complex and inhibits GSK3 activity. β-Ctn then
translocates into the nucleus to activate its target genes. Among
these are CD44, c-Myc, c-Jun, Fos-related antigen-1, cyclin-
D1, transcription factor-1, and COX-2. If APC is inactivated,
phosphorylation of β-Ctn does not occur and it translocates
into the nucleus, even in the absence of WNT [84].
Reactive species initiate a second way to activate trans-
location of β-Ctn into the nucleus [85]. This is brought
about by ROS oxidizing the nucleoredoxin (Nrx) protein
[86]. In its reduced state, Nrx binds to Dvl. When Nrx is
oxidized, it releases Dvl to bind with the β-Ctn-APC com-
plex. With Dvl in the complex, the kinase activity of GSK3
is blocked and β-Ctn translocates into the nucleus to acti-
vate specific target genes. The source of ROS that oxidizes
Nrx in the colon has been shown to be NOX1. Another
frequently dysregulated signal pathway in colon cancer is
Notch. It has been speculated that Notch activation might be
an essential event triggering colorectal cancer. Although the
molecular mechanism of notch activation is incompletely
understood, a strong role for NOX1 has been implicated.
Thus, again, NOX1-produced ROS plays a seminal role in
colon carcinogenesis.
Quercetin, an NDC available from black and green tea,
capers, apples, onions, red grapes, citrus fruit, tomato, broc-
coli, and a number of berries (including raspberry, cranberry,
chokeberry, buckthorn, and the fruit of the prickly pear
cactus) is a strong disruptor of dysregulation of the WNT
pathway. Others are EGCG, curcumin, sulforaphane, soy
isoflavone, epigallocatechin-3-gallate, resveratrol, lycopene,
and piperine (from black pepper) [55•, 87, 88].
Micrornas, RONS, and Inflammation
MicroRNAs (miRNAs) are short, noncoding RNAs that
regulate cell homeostasis by inhibiting translation or causing
degradation of the mRNA of target genes. When inappro-
priately expressed, they can affect the expression of tumor
suppressor genes and oncogenes. In addition, through their
Fig. 1 A steady-state of elevated RONS and pro-inflammatory factors
is a formative driver of colon carcinogenesis. The thesis of this review
is that colon cancer chemopreventative foods and their active constit-
uents work through ameliorating the molecular pathways that are
dysregulated by a continous cycle of pro-inflammatory factors and free
radicals (depicted by the red arrows). The initiating cause of inflam-
mations unclear, but the fecal microbiota is one candidate. Oxidative
stress activates a variety of transcription factors including NF-κB, p53,
β-Ctn-Wnt, and Nrf2 which results in the expression of over 5,000
different genes, including those for growth factors, inflammatory fac-
tors, and cell cycle regulatory molecules. The paramount feature of the
vast majority of chemopreventive substances is their ability to antag-
onize pro-inflammatory factors and reduce the level of RONS. There-
fore, it is expected that molecular pathways most commonly affect by
chemopreventive agents would be those that are dysregulated by pro-
inflammatory factors and free radicals. Green arrow signifies up-
regulation and blue arrows signify progression of processes
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actions on mRNAs, they can cause epigenetic modifications
of the DNA, genomic amplifications and deletions, cellular
stress, and inflammation [89–91]. It has recently been
reported that some miRNA expression is governed by the
binding of the proinflammatory NF-κB transcription factor
to the consequence sequence of the miRNA promoter region
[93]. Inflammation also elicits changes in expression of
miRNA, primarily through the actions of proinflammatory
cytokines. Specifically, proinflammatory signaling cyto-
kines IL-1β, IL-6, and TNF-α alter the expression profile
of miRNAs and the promoter region of miR-146a, which
has a consequence sequence region for NF-κB [92]. Fur-
thermore, the expression profile of miRNAs can be altered
by exogenous H2O2 [93]. Thus, inflammation and ROS are
disruptors of normal miRNA expression. Colon cancer cells
exhibit numerous changes in their miRNA profile as compared
with that of the normal cells/tissues that dysregulate expression
of numerous genes that are involved in all aspects of colon
carcinogenesis.
Several NDCs affect miRNA profiles. Included in this
collection are EGCG, apple polyphenols, coffee polyphe-
nols, ellagic acid, genistein, parthenolide (from chrysanthe-
mum) curcumin, ellagitannin, and indol-3-carbinol. A major
target of miRNAs is regulation of NF-κB. Excellent reviews
discussing NDCs and miRNAs relationships were recently
published by Li et al. [94••] and Parasamka et al. [95•].
Conclusions
A steady state of elevated RONS and proinflammatory factors
is a formative driver of colon carcinogenesis (Fig. 1). The
intention of this review is to assess the thesis that colon cancer
chemopreventive foods and their active constituents work
through ameliorating the molecular pathways that are dysre-
gulated by proinflammatory factors and free radicals. Exten-
sive research has revealed that continued oxidative stress leads
to chronic inflammation, which in turn mediates most chronic
diseases, including colon cancer. Oxidative stress activates a
variety of transcription factors, including NF-κB, AP-1, p53,
β-Ctn-Wnt, and Nrf2, which results in the expression of more
than 5,000 different genes, including those for growth factors,
inflammatory cytokines, chemokines, and cell cycle regulato-
ry molecules [24, 96]. The information in this review clearly
implicates the role of RONS in different phases of inflamma-
tion and carcinogenesis. Therefore, targeting redox-sensitive
pathways and transcription factors with antioxidative NDCs
offers great promise for cancer prevention and therapy. We
have outlined numerous agents that can interfere with redox-
regulated cell signaling pathways. However, NPCs that antag-
onize the enzymes responsible for much of the endogenous
production of ROS (ie, the NOX family members 1, 2, and 4)
are rare. One exception is mastic resin produced from the
evergreen shrub Pistacia lentiscus. It has been shown to
decrease inflammation in Crohn’s disease patients [97]. In
addition, Triantafyllou et al. [98] reported that whereas TNF-
α significantly increased the cellular superoxide production
by NOX1 and 2, mastic gum completely abolished this stim-
ulation. Furthermore, mastic gum inhibited the activity of
PKC activity in cell homogenate, suggesting that NDC
inhibited phosphorylation of NOXA1 by PKC. Thus, mastic
resin may antagonize activation of these two NADPH oxi-
dases. On the other hand, the increase of NOX4 in colon
epithelial cells would not be affected. We hope continued
research will soon identify several and they may be used to
reduce the incidence of colon cancer.
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